Latest News
- June 05, 2025Join CBCC at CPHI China 2025
- June 02, 2025Successfully completed a Phase 1a study for a US-based Innovator Biotech Company!
- May 26, 2025ANDA application for Paclitaxel Injection (Albumin bound) supported by CBCC has received Marketing Authorization from the USFDA
- May 20, 2025We’re Exhibiting at BIO 2025! Visit our booth #3480
- May 15, 2025Join CBCC Global Research at #ASCO25
January 19, 2023
Successful completion of USFDA Inspection with ZERO 483
CBCC Global Research is proud to announce the successful completion of USFDA inspection for Psychiatry PKBE trial with “ZERO 483” at Junagadh site.
We congratulate our dedicated team working on this important trial!